Tri Medix Pharma Private Limited
About Tri Medix Pharma Private Limited
Data last updated:
Tri Medix Pharma Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 April 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2007PTC030772. Its GSTIN is 03AACCT7262N1Z2 (Punjab).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Manohar Lal and Jagmohan Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No: 3203 Sector 35 – D, Chandigarh, India – 160035.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.99 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹1.66 Lakh (net margin 0.8%) and EBITDA of ₹5.73 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 1% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹17.6 Lakh on record. Court records list 6 cases involving the company, including 6 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse No: 3203 Sector 35 – D, Chandigarh, India – 160035
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Tri Medix Pharma Private Limited
The main business activity of Tri Medix Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Tri Medix Pharma Private Limited FY 2025 filings available
Tri Medix Pharma Private Limited reported revenue of ₹1.99 Cr (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Tri Medix Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 11% growth in the latest year. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Tri Medix Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.73 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.66 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Tri Medix Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Tri Medix Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Tri Medix Pharma Private Limited
Tri Medix Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Additek Life Sciences Private Limited | ₹2.01 Cr (FY 2019) | •••• | •••• | 187.0% | •••• | Vadodara, Gujarat, India |
| Zoetic Formulations Private Limited | ₹2.01 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Chennai, Tamil Nadu, India |
| Selexia Biotech Private Limited | ₹2 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Delhi, India |
| Merino Laboratories Private Limited | ₹2 Cr (FY 2025) | •••• | •••• | 404.0% | •••• | Hyderabad, Telangana, India |
| Smotect Private Limited | ₹2 Cr (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Tri Medix Pharma Private Limited this company | ₹1.99 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Chandigarh, India |
| Precious Lifesciences Private Limited | ₹1.99 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Bhubaneswar, Odisha, India |
| VS Life Care Private Limited | ₹1.99 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Muzaffarnagar, Uttar Pradesh, India |
| Assurelife Healthcare Private Limited | ₹1.99 Cr (FY 2025) | •••• | •••• | 77.0% | •••• | Amritsar, Punjab, India |
| Strebuf Labs Private Limited | ₹1.98 Cr (FY 2025) | •••• | •••• | 55.0% | •••• | Ahmedabad, Gujarat, India |
| Ishaana Formulations Private Limited | ₹1.98 Cr (FY 2020) | •••• | •••• | -17.0% | •••• | Dehradun, Uttarakhand, India |
Peers are the five companies nearest above and the five nearest below Tri Medix Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Tri Medix Pharma Private Limited
Tri Medix Pharma Private Limited is audited by G S GAMBHIR & ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G S GAMBHIR & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Tri Medix Pharma Private Limited
Tri Medix Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manohar Lal | Director | 12 Apr 2007 | 19 Years 5 Months | Current |
| Jagmohan Singh | Director | 12 Apr 2007 | 19 Years 5 Months | Current |
| Ravinder Kumar | Director | 12 Apr 2007 | 19 Years 5 Months | Current |
Ownership and Shareholding of Tri Medix Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Tri Medix Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Mar 2013 | State Bank of India | ₹15 Lakh | Open |
| 18 Oct 2011 | Religare Finvest Limited | ₹2.6 Lakh | Open |
Total charge records: 2 View all charges
Legal Cases of Tri Medix Pharma Private Limited
Tri Medix Pharma Private Limited has 6 court cases on record: 6 filed against it. All cases are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 6 | 0 |
Cases on record (4 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by an individual | Disposed |
| District court, SAS Nagar, Punjab | Civil suit | Filed against the company by an individual | Disposed |
| District court, North, Delhi | Court case (CS (COMM.)) | Filed against the company by an individual | Disposed |
| District court, Ludhiana, Punjab | Civil suit | Filed against the company by Vasu Enterprises | Disposed |
Full case history
All 6 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Tri Medix Pharma Private Limited
Tri Medix Pharma Private Limited has a workforce of 10 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Tri Medix Pharma Private Limited
Tri Medix Pharma Private Limited has 3 board changes on record since 2007: 3 appointments. The latest: Jagmohan Singh was appointed as Director on 12 Apr 2007.
Credit Ratings, Litigation & Regulatory Alerts for Tri Medix Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Tri Medix Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Tri Medix Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Tri Medix Pharma Private Limited
Tri Medix Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AACCT7262N1Z2 | Punjab | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Tri Medix Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tri Medix Pharma Private Limited
Tri Medix Pharma is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 April 2007 (19+ years old) and is registered under CIN U24232CH2007PTC030772.
Tri Medix Pharma reported revenue of ₹1.99 Cr for FY 2025 (up 11% YoY).
Tri Medix Pharma has 3 current directors:
- Manohar Lal - Director
- Jagmohan Singh - Director
- Ravinder Kumar - Director
Tri Medix Pharma reported a net profit of ₹1.66 Lakh (net margin 0.8%) and EBITDA of ₹5.73 Lakh (EBITDA margin 2.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Tri Medix Pharma is -11% over three years and 1% over five years. In the latest year (FY 2025) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Tri Medix Pharma is 03AACCT7262N1Z2, registered in Punjab.
The CIN (Corporate Identification Number) of Tri Medix Pharma is U24232CH2007PTC030772. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tri Medix Pharma has 6 court cases on record: 6 filed against it.
Tri Medix Pharma was incorporated on 12 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Tri Medix Pharma by revenue are Additek Life Sciences Private Limited, Zoetic Formulations Private Limited, Selexia Biotech Private Limited, Merino Laboratories Private Limited, Smotect Private Limited and 5 more, all in the Pharma industry (Formulations).
Jagmohan Singh was appointed as Director on 12 Apr 2007. Manohar Lal was appointed as Director on 12 Apr 2007. Ravinder Kumar was appointed as Director on 12 Apr 2007.